NPCE - NeuroPace expects minimal impact of tariffs on its operations and financial results
2025-04-14 16:21:17 ET
More on NeuroPace
- NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript
- NeuroPace, Inc. 2024 Q4 - Results - Earnings Call Presentation
- Stryker, Boston Scientific down as new tariffs impact medtech industry
- NeuroPace refocuses product portfolio; reaffirms 2025 revenue guidance
- Seeking Alpha’s Quant Rating on NeuroPace